首页> 外国专利> Attenuated herpes virus, virus strain, dendritic cell, process to produce a cell, pharmaceutical composition, use of a virus, and process to perform gene therapy on a human or animal patient or to treat or prevent a pathogenic infection or cancer to treat animal patient

Attenuated herpes virus, virus strain, dendritic cell, process to produce a cell, pharmaceutical composition, use of a virus, and process to perform gene therapy on a human or animal patient or to treat or prevent a pathogenic infection or cancer to treat animal patient

机译:减毒疱疹病毒,病毒株,树突状细胞,生产细胞的方法,药物组合物,病毒的用途以及对人或动物患者进行基因治疗或治疗或预防病原性感染或癌症的方法以治疗动物患者

摘要

"ATTENUATED HERPES VIRUS, VIRUS CEPA, DENDRITIC CELL, PROCESS TO PRODUCE A CELL, PHARMACEUTICAL COMPOSITION, USE OF A VIRUS, AND, PROCESS TO PERFORM GENE THERAPY IN A HUMAN PATIENT OR ANY ANIMAL OR ANALYTIC PATIENT OR CANCER TO TREAT ANIMAL PATIENTS "An attenuated herpes virus capable of efficiently infecting a dendritic cell without preventing antigen processing that takes place within the infected cell. The attenuated herpes virus and dendritic cells infected with the virus are usable in immunotherapeutic processes to treat disease.
机译:“固定疱疹病毒,CEPA病毒,树突状细胞,生产细胞,药物成分,使用病毒的过程以及对人类患者或任何动物或分析性患者进行癌症基因治疗的过程”减毒疱疹病毒,能够有效感染树突状细胞而不会阻止被感染细胞内发生的抗原加工。减毒疱疹病毒和感染了该病毒的树突状细胞可用于免疫治疗过程以治疗疾病。

著录项

  • 公开/公告号BR9912653A

    专利类型

  • 公开/公告日2001-05-02

    原文格式PDF

  • 申请/专利权人 BIOVEX LIMITED;

    申请/专利号BR19999912653

  • 发明设计人 ROBERT STUART COFFIN;BENJAMIN CHAIN;

    申请日1999-08-02

  • 分类号C12N15/86;C12N5/10;A61K48/00;

  • 国家 BR

  • 入库时间 2022-08-22 01:25:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号